IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PRESTA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.648
EU - Europa 12.688
AS - Asia 11.948
SA - Sud America 2.038
Continente sconosciuto - Info sul continente non disponibili 789
AF - Africa 329
OC - Oceania 78
Totale 57.518
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.920
CN - Cina 4.264
PL - Polonia 3.958
SG - Singapore 3.749
UA - Ucraina 2.113
BR - Brasile 1.646
IT - Italia 1.510
DE - Germania 1.506
HK - Hong Kong 1.268
VN - Vietnam 811
FI - Finlandia 796
GB - Regno Unito 703
FR - Francia 563
RU - Federazione Russa 455
IN - India 410
TR - Turchia 408
IE - Irlanda 374
BD - Bangladesh 320
CA - Canada 320
AR - Argentina 120
SE - Svezia 120
MX - Messico 115
ZA - Sudafrica 112
NL - Olanda 107
CZ - Repubblica Ceca 102
ES - Italia 102
ID - Indonesia 101
JP - Giappone 98
IQ - Iraq 77
EC - Ecuador 76
AU - Australia 69
CO - Colombia 58
PK - Pakistan 55
JM - Giamaica 47
MA - Marocco 47
VE - Venezuela 46
AT - Austria 45
IL - Israele 43
IR - Iran 43
BE - Belgio 42
CR - Costa Rica 41
SA - Arabia Saudita 40
CL - Cile 34
KE - Kenya 30
LT - Lituania 29
TT - Trinidad e Tobago 28
NG - Nigeria 26
UZ - Uzbekistan 26
CH - Svizzera 24
GT - Guatemala 24
NI - Nicaragua 22
PE - Perù 22
HN - Honduras 21
SV - El Salvador 21
AZ - Azerbaigian 20
GP - Guadalupe 20
MU - Mauritius 20
MY - Malesia 20
EU - Europa 19
JO - Giordania 19
AE - Emirati Arabi Uniti 18
EE - Estonia 18
PH - Filippine 18
TH - Thailandia 18
CW - ???statistics.table.value.countryCode.CW??? 17
PY - Paraguay 17
EG - Egitto 16
KR - Corea 16
KZ - Kazakistan 16
TN - Tunisia 16
DZ - Algeria 14
PA - Panama 14
PR - Porto Rico 14
BG - Bulgaria 13
RO - Romania 13
SC - Seychelles 13
NO - Norvegia 11
NP - Nepal 11
HU - Ungheria 10
TW - Taiwan 10
ET - Etiopia 9
GR - Grecia 9
KG - Kirghizistan 9
UY - Uruguay 9
BO - Bolivia 8
CU - Cuba 8
DK - Danimarca 8
DO - Repubblica Dominicana 8
GE - Georgia 8
LK - Sri Lanka 8
LV - Lettonia 8
PT - Portogallo 8
HR - Croazia 7
LB - Libano 7
OM - Oman 7
SK - Slovacchia (Repubblica Slovacca) 7
SN - Senegal 7
AL - Albania 6
BS - Bahamas 6
NZ - Nuova Zelanda 6
Totale 56.671
Salva come PNG Salva come JPEG
Città #
Warsaw 3.948
Fairfield 3.027
Ashburn 2.665
Woodbridge 2.189
Singapore 1.984
Jacksonville 1.583
San Jose 1.565
Houston 1.527
Hong Kong 1.254
Ann Arbor 1.180
Cambridge 1.175
Seattle 1.110
Wilmington 1.063
Beijing 922
Council Bluffs 900
Chandler 799
The Dalles 740
Princeton 672
Nanjing 581
New York 546
Los Angeles 477
Helsinki 438
Brescia 395
Dallas 370
Dublin 370
Dearborn 337
Istanbul 307
Lauterbourg 303
Columbus 300
Ho Chi Minh City 225
Munich 223
Santa Clara 220
Dong Ket 181
San Francisco 181
Nanchang 180
São Paulo 178
Buffalo 176
Milan 175
Moscow 160
Chicago 156
Des Moines 152
Shenyang 151
Jinan 145
Hebei 144
San Diego 141
Changsha 139
Shanghai 138
Hanoi 126
Phoenix 118
Orem 114
Lancaster 109
Tianjin 106
London 103
Jiaxing 101
Boardman 98
Redondo Beach 97
North Bergen 96
Tokyo 89
Brooklyn 81
Rome 78
Kunming 73
Montreal 70
Turku 69
Jakarta 67
Hangzhou 66
Chennai 65
Brno 64
Atlanta 62
San Mateo 61
Guangzhou 60
Toronto 58
Johannesburg 57
Madrid 55
Verona 55
Boston 54
Porto Alegre 51
Denver 49
Amsterdam 48
Haikou 48
Augusta 47
Rio de Janeiro 46
Zhengzhou 45
Charlotte 44
Ningbo 44
Stockholm 44
Lanzhou 42
Nuremberg 42
Manchester 40
Mexico City 40
Washington 37
Belo Horizonte 36
Brussels 35
Frankfurt am Main 35
Kocaeli 35
Poplar 34
Brasília 33
Leawood 33
Curitiba 30
Mumbai 30
Dhaka 29
Totale 39.041
Salva come PNG Salva come JPEG
Nome #
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 419
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 416
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 386
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 371
The nanostructured secretome 371
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 356
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 341
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 333
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 322
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 319
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 319
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 315
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 312
Claudin3 is localized outside the tight junctions in human carcinomas 310
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 309
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 307
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 306
Different effects of mucosal, beef lung, and chemically modified heparin on selected biological properties of basic fibroblast growth factor 301
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 301
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 298
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 297
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 297
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 295
Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance 295
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 293
Ruolo dell’eparina e dei proteoglicani eparan solfati nella modulazione dell’angiogenesi indotta dal fattore di crescita basico dei fibroblasti 290
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 287
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 286
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 285
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 283
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 277
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 274
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 271
Mammalian tumor xenografts induce neovascularization in zebrafish embryos. 270
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 267
Role of the soluble pattern recognition receptor PTX3 in vascular biology. 263
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 260
Zebrafish disease models in hematology: Highlights on biological and translational impact 257
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. 253
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 247
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 242
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 239
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 234
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 233
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 232
Long pentraxin-3 follows and modulates bladder cancer progression 232
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 229
Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. 226
Anti-angiogenic activity of the purine analog 6-thioguanine. 226
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 225
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 225
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 224
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 222
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 221
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 219
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 219
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 217
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 216
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 216
The zebrafish/tumor xenograft angiogenesis assay. 213
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 213
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 213
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 211
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305. 209
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 207
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 207
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 204
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 204
Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver. 203
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 202
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 201
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 200
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 199
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 199
Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis 199
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy 199
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 198
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 198
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 196
Atypical chemokine receptor 3 generates guidance cues for CXCL12-mediated endothelial cell migration 195
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 194
Ascorbic acid rescues cardiomyocyte development in Fgfr1-/- murineembryonic stem cells 194
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. 193
Total reflection X-Ray fluorescence spectroscopy to study Pb and Zn accumulation in zebrafish embryos 193
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 192
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 190
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 190
Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach 190
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 189
A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity. 187
Calcitonin receptor-like receptor guides arterial differentiation in zebrafish. 186
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 186
Beta-Galactosylceramidase deficiency: neurovascular implications 186
Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases 185
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 184
Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications 184
Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. 183
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 182
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 181
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 180
Totale 24.575
Salva come PNG Salva come JPEG
Categoria #
all - tutte 250.626
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 250.626
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.059 0 0 0 0 41 137 191 182 150 430 232 696
2022/20232.386 417 113 114 138 178 627 17 188 315 37 112 130
2023/20242.949 186 98 337 117 124 466 123 127 680 127 58 506
2024/20256.143 86 57 40 861 652 574 516 250 708 468 1.139 792
2025/202613.407 1.327 1.675 1.078 1.838 1.441 883 2.044 444 792 1.113 538 234
2026/20274.569 597 763 1.013 1.741 455 0 0 0 0 0 0 0
Totale 57.518